Glytec, LLC, provides an intelligent Glycemic Management platform for inpatient insulin management. Used in hundreds of care settings across the United States, Glytec, supports hospitals moving away from sliding scale insulin and other manual approaches by providing FDA-cleared dosing support and real-time visibility into glycemic risk.
Glytec’s Command Center helps teams review glycemic performance and monitor risk across units using dashboards and retrospective review tools. Leaders can compare trends across facilities and support quality improvement efforts with real-time AI-powered reporting.
Glytec’s FDA-cleared Glucommander IV and Glucommander SubQ provide real-time insulin dosing recommendations, and support patient monitoring, including dose-adjustment suggestions based on patient response. Glytec has collaborated with Roche Diagnostics to make Glucommander available on handheld point-of-care devices.
